Boothbay Fund Management’s HCA Healthcare HCA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $764K | Buy |
1,614
+603
| +60% | +$304K | 0.01% | 1097 |
|
|
2025
Q4 | $472K | Buy |
+1,011
| New | +$469K | 0.01% | 1176 |
|
|
2025
Q3 | – | Sell |
-1,776
| Closed | -$680K | – | 1984 |
|
|
2025
Q2 | $680K | Sell |
1,776
-1,834
| -51% | -$661K | 0.01% | 810 |
|
|
2025
Q1 | $1.25M | Buy |
3,610
+991
| +38% | +$319K | 0.03% | 558 |
|
|
2024
Q4 | $786K | Buy |
+2,619
| New | +$915K | 0.02% | 713 |
|
|
2024
Q3 | – | Sell |
-3,879
| Closed | -$1.25M | – | 1743 |
|
|
2024
Q2 | $1.25M | Buy |
3,879
+2,938
| +312% | +$955K | 0.03% | 643 |
|
|
2024
Q1 | $314K | Sell |
941
-1,780
| -65% | -$544K | 0.01% | 1178 |
|
|
2023
Q4 | $737K | Sell |
2,721
-12,960
| -83% | -$3.2M | 0.02% | 826 |
|
|
2023
Q3 | $3.86M | Buy |
+15,681
| New | +$4.29M | 0.09% | 292 |
|
|
2022
Q3 | – | Sell |
-2,814
| Closed | -$473K | – | 2378 |
|
|
2022
Q2 | $473K | Buy |
2,814
+1,496
| +114% | +$321K | 0.01% | 1207 |
|
|
2022
Q1 | $330K | Sell |
1,318
-614
| -32% | -$154K | 0.01% | 1555 |
|
|
2021
Q4 | $496K | Buy |
+1,932
| New | +$473K | 0.01% | 1019 |
|
|
2021
Q1 | – | Sell |
-10,337
| Closed | -$1.7M | – | 1641 |
|
|
2020
Q4 | $1.7M | Buy |
10,337
+1,223
| +13% | +$179K | 0.06% | 314 |
|
|
2020
Q3 | $1.14M | Buy |
9,114
+1,022
| +13% | +$126K | 0.07% | 392 |
|
|
2020
Q2 | $785K | Sell |
8,092
-8,213
| -50% | -$854K | 0.05% | 452 |
|
|
2020
Q1 | $1.47M | Buy |
16,305
+13,803
| +552% | +$1.79M | 0.12% | 209 |
|
|
2019
Q4 | $370K | Buy |
2,502
+340
| +16% | +$45.7K | 0.03% | 565 |
|
|
2019
Q3 | $260K | Buy |
+2,162
| New | +$279K | 0.02% | 607 |
|
|
2018
Q4 | – | Sell |
-3,600
| Closed | -$501K | – | 743 |
|
|
2018
Q3 | $501K | Buy |
+3,600
| New | +$448K | 0.05% | 364 |
|
|
2018
Q2 | – | Sell |
-3,400
| Closed | -$330K | – | 804 |
|
|
2018
Q1 | $330K | Sell |
3,400
-296
| -8% | -$28.7K | 0.04% | 438 |
|
|
2017
Q4 | $325K | Buy |
3,696
+896
| +32% | +$72K | 0.05% | 404 |
|
|
2017
Q3 | $223K | Sell |
2,800
-4,280
| -60% | -$344K | 0.04% | 474 |
|
|
2017
Q2 | $617K | Buy |
7,080
+3,646
| +106% | +$308K | 0.13% | 183 |
|
|
2017
Q1 | $306K | Buy |
+3,434
| New | +$286K | 0.06% | 423 |
|
|
2016
Q3 | – | Sell |
-3,424
| Closed | -$264K | – | 750 |
|
|
2016
Q2 | $264K | Buy |
+3,424
| New | +$270K | 0.1% | 281 |
|
Other funds holding HCA
VCM
VPM
Boothbay Fund Management's HCA Position: Q1 2026 in Review
Boothbay Fund Management increased its HCA Healthcare (HCA) stake by 60% in Q1 2026, buying an estimated $304K and bringing the position to 1,614 shares worth $764K. The position accounts for 0.01% of the portfolio, ranked #1097.
Boothbay Fund Management first reported a position in HCA in Q2 2016 and has held it in 25 quarters since. The position peaked at $3.86M in Q3 2023. 1,414 funds tracked by Wall St. Rank hold HCA as of Q1 2026.
- Boothbay Fund Management held 1,614 shares of HCA Healthcare worth $764K as of Q1 2026.
- Boothbay Fund Management bought 603 HCA Healthcare shares in Q1 2026, an estimated $304K.
- HCA Healthcare made up 0.01% of Boothbay Fund Management's portfolio in Q1 2026, its #1097 holding.
- Boothbay Fund Management first reported a position in HCA Healthcare in Q2 2016 and has held it in 25 quarters since.
- Boothbay Fund Management's HCA Healthcare position peaked at $3.86M in Q3 2023.
- 1,414 funds tracked by Wall St. Rank held HCA Healthcare as of Q1 2026.
Based on Boothbay Fund Management's 13F filing for Q1 2026, filed 15 May 2026.